Upgrade to SI Premium - Free Trial

Cellectar Biosciences (CLRB)

1.21 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/2/26)

Latest Headlines

Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Tuesday, November 10, 2026 November 2, 2026 8:00 AM - StreetInsider Cellectar reports 8-year complete response in DLBCL patient using iopofosine October 27, 2026 7:15 AM - StreetInsider Cellectar Biosciences Reports Case Study Highlighting Complete Response Lasting More Than Eight Years in Heavily Pretreated DLBCL Patient Treated with Iopofosine I 131 October 27, 2026 7:15 AM - StreetInsider Cellectar reports Phase 2b subgroup data for iopofosine I 131 in WM October 15, 2026 7:01 AM - StreetInsider Cellectar Biosciences Presents Compelling Efficacy Data from Phase 2b CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Relapsed/Refractory to BTK Inhibitor Therapy at the International Works October 15, 2026 7:00 AM - StreetInsider Cellectar to present Phase 2 iopofosine data at WM workshop September 29, 2026 7:30 AM - StreetInsider Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Worksho September 29, 2026 7:30 AM - StreetInsider Form SCHEDULE 13G Cellectar Biosciences, Filed by: Caligan Partners LP August 14, 2026 4:15 PM - SEC Filing Form SCHEDULE 13G Cellectar Biosciences, Filed by: SILVERARC CAPITAL MANAGEMENT, LLC August 14, 2026 12:11 PM - SEC Filing Form SCHEDULE 13G Cellectar Biosciences, Filed by: STEMPOINT CAPITAL LP August 14, 2026 12:00 PM - SEC Filing Form SCHEDULE 13G Cellectar Biosciences, Filed by: BALYASNY ASSET MANAGEMENT L.P. August 14, 2026 6:14 AM - SEC Filing Form SCHEDULE 13G Cellectar Biosciences, Filed by: Bleichroeder LP August 13, 2026 4:12 PM - SEC Filing Form 8-K Cellectar Biosciences, For: Aug 13 August 13, 2026 7:25 AM - SEC Filing Cellectar Biosciences (CLRB) Misses Q2 EPS by 9c August 13, 2026 7:25 AM - StreetInsider Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates August 13, 2026 7:15 AM - StreetInsider Form 10-Q Cellectar Biosciences, For: Jun 30 August 13, 2026 7:01 AM - SEC Filing Form SCHEDULE 13G Cellectar Biosciences, Filed by: Empery Asset Management, LP August 4, 2026 10:06 AM - SEC Filing Full Article List